ESMAEILI, S.; ZABETI, A. Ocrelizumab-induced Psoriasis in A Patient with Relapsing-Remitting Multiple Sclerosis. European Journal of Medical and Health Sciences, [S. l.], v. 5, n. 3, p. 1–2, 2023. DOI: 10.24018/ejmed.2023.5.3.1697. Disponível em: https://ej-med.org/index.php/ejmed/article/view/1697. Acesso em: 14 feb. 2025.